Skip to main content
SpringerLink
Log in

Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017–2020

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Objectives

To investigate the correlations between physical activity (PA) and metabolic associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) within a substantial population-based survey, and to examine the association between PA and liver fibrosis (LF).

Methods

Data from the 2017–2020 NHANES cycle were utilized in this study. PA was divided into four types: leisure-time PA (LTPA), transportation-related PA (TPA), occupational PA (OPA) and total time PA (total PA, which is composed of OPA, TPA and LTPA). Weighted logistic regression models were performed to analyze the associations between PA and MAFLD/MASLD and LF. Mediation analysis was used to explore whether LTPA completely mediated the statistically significant relationship between total PA and MAFLD/MASLD or LF.

Results

The study encompassed a sample size of 5897 participants aged 20 years and above, among the total participants, 2568 individuals with MAFLD and 2588 individuals with MASLD. There was no statistically significant correlation observed between OPA/TPA and MAFLD/MASLD and LF; however, active LTPA demonstrated an inverse association with MAFLD/MASLD (OR: 0.548; 95% CI: 0.458, 0.656/OR: 0.543; 95% CI: 0.453, 0.650), as well as a negative correlation with significant/advanced LF (OR: 0.457; 95% CI: 0.334,0.625/OR: 0.427; 95% CI: 0.295,0.619). There was also a significant inverse association between total PA and MAFLD/MASLD or LF, but this association was carried by the difference in LTPA.

Conclusion

Participation in active LTPA is associated with a reduced likelihood of MAFLD/MASLD and LF, while neither OPA nor TPA can replace these effects of LTPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Availability of data and material

Publicly available datasets were analyzed in this study. The data can be found at: https://www.cdc.gov/nchs/nhanes/index.htm.

Abbreviations

BMI:

Body mass index

CAP:

Controlled attenuation parameters

CDC:

Disease control and prevention

CI:

Confidence interval

HBV:

Hepatitis B virus

HCV:

Hepatitis C virus

LF:

Liver fibrosis

LSM:

Liver stiffness measurement

LTPA:

Leisure-time physical activity

MAFLD:

Metabolic associated fatty liver disease

MASLD:

Metabolic dysfunction-associated steatotic liver disease

NAFLD:

Non-alcoholic fatty liver disease

NCHS:

National Center for Health Statistics

NHANES:

National Health and Nutrition Examination Survey

OPA:

Occupational physical activity

OR:

Odds ratios

SD:

Standard deviation

Total PA:

Total-time physical activity

TPA:

Transportation-related physical activity

VCTE:

Vibration-controlled transient elastography

References

  1. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–98. May.

    Article  PubMed  Google Scholar 

  2. Nan Y, An J, Bao J, Chen H, Chen Y, Ding H, et al. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol. 2021;75:454–61.

    Article  CAS  PubMed  Google Scholar 

  3. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ. 2018;18;362:k2817. Jul.

    Article  Google Scholar 

  4. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–71. https://doi.org/10.1016/j.jhep.2018.09.014.

    Article  PubMed  Google Scholar 

  5. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8:1844–50.

    Article  Google Scholar 

  6. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450–5.

    Article  CAS  PubMed  Google Scholar 

  7. Radaelli MG, Martucci F, Perra S, Accornero S, Castoldi G, Lattuada G, Manzoni G, et al. NAFLD/NASH in patients with type 2 diabetes and related treatment options. J Endocrinol Invest. 2018;41(5):509–21.

    Article  CAS  PubMed  Google Scholar 

  8. Eslam M , Newsome PN , Sarin SK , Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202–209. https://doi.org/10.1016/j.jhep.2020.03.039 .

  9. Eslam M, Sarin SK, Wong VWS, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889–919.

    Article  PubMed  Google Scholar 

  10. Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology. 2021;73:1194–8.

    Article  PubMed  Google Scholar 

  11. Ratziu V, Rinella M, Beuers U, Loomba R, Anstee QM, Harrison S, et al. The times they are a‑changin’ (for NAFLD as well). J Hepatol. 2020;73:1307–9.

    Article  PubMed  Google Scholar 

  12. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023 Jun 20:S0168–8278(23)00418‑X. .

  13. Ciardullo S, Carbone M, Invernizzi P, Perseghin G. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. 2023;17.

  14. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–61. Sep.

    Article  PubMed  Google Scholar 

  15. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–22. Jul.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jakicic JM, Rogers RJ, Davis KK, Collins KA. Role of Physical Activity and Exercise in Treating Patients with Overweight and Obesity. Clin Chem. 2018;64(1):99–107. Jan.

    Article  CAS  PubMed  Google Scholar 

  17. Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, et al. Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;1;54(2):353–68. Feb.

    Article  Google Scholar 

  18. Tucker WJ, Fegers-Wustrow I, Halle M, Haykowsky MJ, Chung EH, Kovacic JC. Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4. J Am Coll Cardiol. 2022 Sep 13;80(11):1091–1106.

  19. Smith PJ, Merwin RM. The Role of Exercise in Management of Mental Health Disorders: An Integrative Review. Annu Rev Med. 2021;27;72:45–62. Jan.

    Article  Google Scholar 

  20. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;9;313(22):2263–73. Jun.

    Article  Google Scholar 

  21. Wang X, Wang A, Zhang R, Cheng S, Pang Y. Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease. Nutrients. 2022;11;14(20):4222. Oct.

    Article  Google Scholar 

  22. Chun HS, Lee M, Lee HA, Oh SY, Baek HJ, Moon JW, et al. Association of Physical Activity With Risk of LF, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023;21(2):358–369.e1. 2.

    Article  CAS  PubMed  Google Scholar 

  23. Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156(5):1264–1281.e4.

    Article  PubMed  Google Scholar 

  24. Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009;6(6):790–804. Nov.

    Article  PubMed  Google Scholar 

  25. Divney AA, Murillo R, Rodriguez F, Mirzayi CA, Tsui EK, Echeverria SE. Diabetes Prevalence by Leisure‑, Transportation-, and Occupation-Based Physical Activity Among Racially/Ethnically Diverse U.S. Adults. Diabetes Care. 2019;42(7):1241–7. Jul.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chu NM, Hong J, Harasemiw O, Chen X, Fowler KJ, al Dasgupta I. Global Renal Exercise Network. Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011–2014). Nephrol Dial Transplant. 2022;19;37(11):2180–9. Oct.

    Article  Google Scholar 

  27. US Department of Health and Human Services . Physical Activity Guidelines for Americans. https://health.gov/sites/default/files/2019-09/paguide.pdf (August 2020, date last accessed).

  28. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):14–S31.

    Article  Google Scholar 

  29. Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–30.

    Article  PubMed  Google Scholar 

  30. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.

    Article  PubMed  Google Scholar 

  31. Centers for Disease Control. Prevention . Testing for HCV infection: an update of guidance for clinicians and laboratorians. Mmwr Morb Mortal Wkly Rep. 2013;62:362–5.

    Google Scholar 

  32. Coffin CS, Zhou K, Terrault NA. New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection. Gastroenterology. 2019;156(e3):355–68.

    Article  CAS  PubMed  Google Scholar 

  33. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008;48(4):606–13. Apr.

    Article  PubMed  Google Scholar 

  34. Yang C, Jia X, Wang Y, Fan J, Zhao C, Yang Y, et al. Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018. BMC Geriatr. 2022;19;22(1):979. Dec.

    Article  Google Scholar 

  35. Guerra JVS, Dias MMG, Brilhante AJVC, Terra MF, García-Arévalo M, Figueira ACM. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients. 2021;18;13(8):2830. Aug.

    Article  Google Scholar 

  36. El-Agroudy NN, Kurzbach A, Rodionov RN, O’Sullivan J, Roden M, Birkenfeld AL. Are Lifestyle Therapies Effective for NAFLD Treatment? Trends Endocrinol Metab. 2019;30(10):701–9. Oct.

    Article  CAS  PubMed  Google Scholar 

  37. Shojaee-Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, et al. Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD. J Clin Endocrinol Metab. 2016;101(11):4219–28.

    Article  CAS  PubMed  Google Scholar 

  38. Martins C, Morgan L, Truby H. A review of the effects of exercise on appetite regulation: an obesity perspective. Int J Obes (2005). 2008;32(9):1337–1347.

  39. Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011). J Hepatol. 2015;63(2):486–93.

    Article  PubMed  Google Scholar 

  40. Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–31.

    Article  PubMed  Google Scholar 

  41. Longo M, Meroni M, Paolini E, Macchi C, Dongiovanni P. Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? Metabolism. 2021;117:154708.

    Article  CAS  PubMed  Google Scholar 

  42. Guarino M, Kumar P, Felser A, Terracciano LM, Guixé-Muntet S, Humar B, et al. Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. Cancers (basel). 2020;29;12(6):1407. May.

    Article  Google Scholar 

  43. Saran U, Guarino M, Rodríguez S, Simillion C, Montani M, Foti M, et al. Anti-tumoral effects of exercise on hepatocellular carcinoma growth. Hepatol Commun. 2018;22;2(5):607–20. Mar.

    Article  Google Scholar 

  44. Hamer M, Sabia S, Batty GD, Shipley MJ, Tabák AG, Singh-Manoux A, et al. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation. 2012;21;126(8):928–33. Aug.

    Article  Google Scholar 

  45. Li H, Wu X, Bai Y, Wei W, Li G, Fu M, et al. Physical activity attenuates the associations of systemic immune-inflammation index with total and cause-specific mortality among middle-aged and older populations. Sci Rep. 2021;15;11(1):12532. Jun.

    Article  Google Scholar 

  46. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;21;380(9838):219–29. Jul.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zhujiang Hospital of Southern Medical University, 510150, Guangzhou, Guangdong, China

    Minhua Li

Authors
  1. Minhua Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minhua Li.

Ethics declarations

Conflict of interest

M. Li declares that he/she has no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, M. Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017–2020. Wien Klin Wochenschr 136, 258–266 (2024). https://doi.org/10.1007/s00508-023-02314-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-023-02314-0

Keywords

Search

Navigation